Tag: immunoassay

Lecanemab four-year efficacy and safety data to be presented at AAIC 2025

STOCKHOLM, July 22, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®), including...

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

Immunoassay Market, Strategies, Trends, and Forecast Report 2025, with Comprehensive Profiles of Over 60 Companies Driving Immunoassay Growth

The diagnostic industry sees a surge in demand for rapid solutions, with immunoassays leading the charge. Fueled by genetic advances, multiplex assays become essential, expanding into rapid diagnostics and consumer markets. Analyze profiles of 60+ companies for informed investment decisions.

The diagnostic industry sees a surge in demand for rapid solutions, with immunoassays leading the charge. Fueled by genetic advances, multiplex assays become essential, expanding into rapid diagnostics and consumer markets. Analyze profiles of 60+ companies for informed investment decisions.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsImmunoassay

Stardog Appoints Sara Golbourn as Chief Revenue Officer to Scale the Enterprise Answer Engine

QNB Corp. Reports Earnings for Second Quarter 2025

Adam Breen Joins Accruit as Vice President of Product and Strategy

Tag: immunoassay

Lecanemab four-year efficacy and safety data to be presented at AAIC 2025

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Immunoassay Market, Strategies, Trends, and Forecast Report 2025, with Comprehensive Profiles of Over 60 Companies Driving Immunoassay Growth

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us